title: Socioeconomic aspects of heart transplantation.
abstract: Heart transplantation is an established treatment modality for end-stage cardiac disease. Unfortunately, relative to other health care priorities, heart transplantation has fallen into disrepute. Efforts to reform the health care system have focused on three fundamental issues--cost, quality, and access. On each count, heart transplantation is vulnerable to criticism. Managed care is an incremental approach to health care reform that imposes fiscal constraint on providers. This constraint is expressed in the form of capitation which, in turn, requires providers to assume risk and accept economic responsibility for clinical decisions. While the need for transplantation is considerable, there are both clinical and economic factors limiting the overall level of activity. In 1993, over 2200 heart transplants were performed in the United States on people who were dying of end-stage cardiac disease. The total demand for heart transplantation was estimated to be about 5900 persons, which was not met due to an insufficient supply of donor hearts. Absent donors, the fiscal consequences of heart transplantation are minimized. In 1993, actuaries estimated that the total charge per heart transplant was $209,100. By designating centers based on price and quality considerations, managed care plans have reduced this per procedure expense to less than $100,000. While the benefits of transplantation are noteworthy, there are still concerns. Sixty percent of patients report that they are able to work, but only 30% do so. Employers hope to improve upon this record by expanding the designated center approach. In conclusion, the future of heart transplantation is unclear. Opportunities for innovation are limited, although the management of heart failure is an area of increased interest.
authors.affiliation: Section of Health Services Evaluation, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: R W
authors.initials: RW
authors.lastname: Evans
mesh_terms: D003362:Cost-Benefit Analysis; D005102:Health Expenditures; D016027:Heart Transplantation / Q000191:economics / Q000706:statistics & numerical data; D018594:Human Body; D006801:Humans; D011788:Quality of Life; D012959:Socioeconomic Factors; D014019:Tissue Donors / Q000600:supply & distribution; D009927:Tissue and Organ Procurement